Viggo Van Tendeloo

8.9k citations

155 papers · 6.5k indexed · 1 hit paper · h-index 45

Immunology top 0.5%
- Immunotherapy and Immune Responses 92
- Immune Cell Function and Interaction 45
- T-cell and B-cell Immunology 34
Oncology top 1%
- CAR-T cell therapy research 44
Hematology top 2%
Molecular Biology top 2%
- RNA Interference and Gene Delivery 35
- Renal and related cancers 12
- vaccines and immunoinformatics approaches 9
Virology top 5%
Genetics
- Virus-based gene therapy research 19

Co-authors: Zwi Berneman Evelien Smits Peter Ponsaerts Sébastien Anguille Eva Lion Nathalie Cools Heleen H. Van Acker Griet Nijs
Cited by: Immunology Oncology Hematology
Journals: Journal of Clinical Oncology (3 papers)SHILAP Revista de lepidopterología (2 papers)Blood (6 papers)
Partner nations: Belgium Uganda United Kingdom

In The Last Decade

Viggo Van Tendeloo

154 papers receiving 6.4k citations

Hit Papers

align trajectories log scale

Peers

Countries citing papers authored by Viggo Van Tendeloo

Since Specialization

Citations

This map shows the geographic impact of Viggo Van Tendeloo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Viggo Van Tendeloo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Viggo Van Tendeloo more than expected).

Fields of papers citing papers by Viggo Van Tendeloo

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Viggo Van Tendeloo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Viggo Van Tendeloo. The network helps show where Viggo Van Tendeloo may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Viggo Van Tendeloo, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Viggo Van Tendeloo Line = papers co-authored together Viggo Van Tendeloo links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Shared lung and joint T cell repertoire in early rheumatoid arthritis driven by cigarette smoking Annals of the Rheumatic Diseases ·Koen Venken,Matthias Jarlborg,Frederik Stevenaert,Thomas Malfait,Carolien Vlieghe,Yann Abraham,Teddy Manuello,Tine Decruy,Stijn Vanhee,Hans Wils,Pieter J. Peeters,Philippe Carron,Filip Van den Bosch,Viggo Van Tendeloo,Bart N. Lambrecht,Ruth Wittoek,Peggy Jacques,Dirk Elewaut	2024	1
2	Diagnosing Viral Infections Through T-Cell Receptor Sequencing of Activated CD8+ T Cells The Journal of Infectious Diseases ·Alexandra Vujkovic,My Kieu Ha,Tessa de Block,Lida van Petersen,Isabel Brosius,Caroline Theunissen,Sabrina H. van Ierssel,Esther Bartholomeus,Wim Adriaensen,Guido Vanham,George Elias,Pierre Van Damme,Viggo Van Tendeloo,Philippe Beutels,Maartje Van Frankenhuijsen,Erika Vlieghe,Benson Ogunjimi,Kris Laukens,Pieter Meysman,Koen Vercauteren	2023	3
3	In vitro expansion of Wilms’ tumor protein 1 epitope-specific primary T cells from healthy human peripheral blood mononuclear cells STAR Protocols ·Sanne van der Heijden,Donovan Flumens,Maarten Versteven,Stefanie Peeters,Hans De Reu,Diana Campillo-Davó,Yannick Willemen,Benson Ogunjimi,Viggo Van Tendeloo,Zwi Berneman,Sébastien Anguille,Evelien Smits,Eva Lion	2023	2
4	Activation of Interferon-Stimulated Genes following Varicella-Zoster Virus Infection in a Human iPSC-Derived Neuronal In Vitro Model Depends on Exogenous Interferon-α Viruses ·Marlies Boeren,Elise Van Breedam,Tamariche Buyle-Huybrecht,Marielle Lebrun,Pieter Meysman,Catherine Sadzot‐Delvaux,Viggo Van Tendeloo,Geert Mortier,Kris Laukens,Benson Ogunjimi,Peter Ponsaerts,Peter Delputte	2022	2
5	Preexisting memory CD4 T cells in naïve individuals confer robust immunity upon hepatitis B vaccination eLife ·George Elias,Pieter Meysman,Esther Bartholomeus,Nicolas De Neuter,Nina Keersmaekers,Arvid Suls,Hilde Jansens,Aisha Souquette,Hans De Reu,Marie‐Paule Emonds,Evelien Smits,Eva Lion,Paul G. Thomas,Geert Mortier,Pierre Van Damme,Philippe Beutels,Kris Laukens,Viggo Van Tendeloo,Benson Ogunjimi	2022	11
6	New targets for therapy: antigen identification in adults with B-cell acute lymphoblastic leukaemia Cancer Immunology Immunotherapy ·Stephanie Jordaens,Leah Cooksey,Laurie Freire Boullosa,Viggo Van Tendeloo,Evelien Smits,Ken Mills,Kim Orchard,Barbara‐ann Guinn	2020	3
7	Serum profiling identifies ibrutinib as a treatment option for young adults with B‐cell acute lymphoblastic leukaemia British Journal of Haematology ·Stephanie Jordaens,Leah Cooksey,Stephanie A. Bonney,Laurence Orchard,Matthew Coutinho,Viggo Van Tendeloo,Ken Mills,Kim Orchard,Barbara‐ann Guinn	2020	4
8	CD56 Homodimerization and Participation in Anti-Tumor Immune Effector Cell Functioning: A Role for Interleukin-15 Cancers ·Heleen H. Van Acker,Zoë P. Van Acker,Maarten Versteven,Peter Ponsaerts,Daniela Pende,Zwi Berneman,Sébastien Anguille,Viggo Van Tendeloo,Evelien Smits	2019	8
9	Memory CD4+ T cell receptor repertoire data mining as a tool for identifying cytomegalovirus serostatus Genes and Immunity ·Nicolas De Neuter,Esther Bartholomeus,George Elias,Nina Keersmaekers,Arvid Suls,Hilde Jansens,Evelien Smits,Niel Hens,Philippe Beutels,Pierre Van Damme,Geert Mortier,Viggo Van Tendeloo,Kris Laukens,Pieter Meysman,Benson Ogunjimi	2018	13
10	GTL001, A Therapeutic Vaccine for Women Infected with Human Papillomavirus 16 or 18 and Normal Cervical Cytology: Results of a Phase I Clinical Trial Clinical Cancer Research ·Pierre Van Damme,Myriam Bouillette-Marussig,Annick Hens,Ilse De Coster,Christophe Depuydt,Anne Goubier,Viggo Van Tendeloo,Nathalie Cools,Herman Goossens,Thierry Hercend,Benedikt Timmerman,Marie-Christine Bissery	2016	34
11	IL-15 receptor alpha as the magic wand to boost the success of IL-15 antitumor therapies: The upswing of IL-15 transpresentation Pharmacology & Therapeutics ·Johan MJ Van den Bergh,Eva Lion,Viggo Van Tendeloo,Evelien Smits	2016	25
12	Bisphosphonates for cancer treatment: Mechanisms of action and lessons from clinical trials Pharmacology & Therapeutics ·Heleen H. Van Acker,Sébastien Anguille,Yannick Willemen,Evelien Smits,Viggo Van Tendeloo	2015	167
13	Exploring the Impact of Exposure to Primary Varicella in Children on Varicella-Zoster Virus Immunity of Parents Viral Immunology ·Benson Ogunjimi,Evelien Smits,Niel Hens,Annick Hens,Kevin Lenders,Margareta Ieven,Viggo Van Tendeloo,Pierre Van Damme,Philippe Beutels	2011	33
14	Standardized Limbal Epithelial Stem Cell Graft Generation and Transplantation Tissue Engineering Part C Methods ·Nadia Zakaria,Carina Koppen,Viggo Van Tendeloo,Zwi Berneman,Andrew Hopkinson,Marie‐José Tassignon	2009	44
15	THP-1 monocytes but not macrophages as a potential alternative for CD34+ dendritic cells to identify chemical skin sensitizers Toxicology and Applied Pharmacology ·Nathalie Lambrechts,Sandra Verstraelen,Hanne Lodewyckx,Ana P. Felício,Jef Hooyberghs,Hilda Witters,Viggo Van Tendeloo,Paul Van Cauwenberge,Inge Nelissen,Rosette Van Den Heuvel,Greet Schoeters	2009	19
16	Can cell therapy heal a spinal cord injury? Spinal Cord ·Mark W Ronsyn,Zwi Berneman,Viggo Van Tendeloo,Philippe G. Jorens,Peter Ponsaerts	2008	49
17	Immunosuppression induced by immature dendritic cells is mediated by TGF‐β/IL‐10 double‐positive CD4⁺ regulatory T cells Journal of Cellular and Molecular Medicine ·Nathalie Cools,Viggo Van Tendeloo,Evelien Smits,Marc Lenjou,Griet Nijs,Dirk R. Van Bockstaele,Zwi Berneman,Peter Ponsaerts	2007	66
18	Cellular Immunotherapy for Cytomegalovirus and HIV-1 Infection Journal of Immunotherapy ·Glenn A. Van den Bosch,Peter Ponsaerts,Guido Vanham,Dirk R. Van Bockstaele,Zwi Berneman,Viggo Van Tendeloo	2006	6
19	Highly Efficient mRNA-Based Gene Transfer in Feeder-Free Cultured H9 Human Embryonic Stem Cells Cloning and Stem Cells ·Peter Ponsaerts,Sjaak van der Sar,Viggo Van Tendeloo,Philippe G. Jorens,Zwi Berneman,Prim B. Singh	2004	16
20	Generation of dendritic cells from bone marrow progenitors using GM‐CSF, TNF‐α, and additional cytokines: antagonistic effects of IL‐4 and IFN‐γ and selective involvement of TNF‐α receptor‐1 Immunology ·Filip Lardon,Snoeck Hw,Zwi Berneman,Viggo Van Tendeloo,Griet Nijs,Marc Lenjou,Els Henckaerts,C. J. BOECKXTAENS,Peter Vandenabeele,Luc Kestens,Dirk R. Van Bockstaele,Guido Vanham	1997	82

About Viggo Van Tendeloo

Viggo Van Tendeloo is a scholar working on Immunology, Oncology and Virology, having authored 155 papers that have together received 6.5k indexed citations. Recurring topics across this work include Immunotherapy and Immune Responses (92 papers), Immune Cell Function and Interaction (45 papers), CAR-T cell therapy research (44 papers), RNA Interference and Gene Delivery (35 papers), T-cell and B-cell Immunology (34 papers), Virus-based gene therapy research (19 papers), Renal and related cancers (12 papers) and vaccines and immunoinformatics approaches (9 papers). The work is most often cited by research in Immunology (4.1k citations), Oncology (2.3k citations) and Hematology (493 citations). Viggo Van Tendeloo has collaborated with scholars based in Belgium, Uganda and United Kingdom. Frequent co-authors include Zwi Berneman, Evelien Smits, Peter Ponsaerts, Sébastien Anguille, Eva Lion, Nathalie Cools, Heleen H. Van Acker, Griet Nijs, Dirk R. Van Bockstaele and Yannick Willemen. Their work appears in journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Blood.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact